Perkinelmer Inc (PKI): Joel S Goldberg , officer of Perkinelmer Inc sold 38,095 shares on Sep 22, 2016. The Insider selling transaction was reported by the company on Sep 22, 2016 to the Securities and Exchange Commission. The shares were sold at $55.00 per share for a total value of $2,095,225.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 13, 2016, Daniel R Tereau (officer ) sold 18,866 shares at $52.00 per share price.On Aug 25, 2016, Kenton J Sicchitano (director) sold 15,189 shares at $54.87 per share price.Also, On Aug 18, 2016, Patrick J Sullivan (director) sold 8,308 shares at $54.74 per share price.On Jun 3, 2016, Alexis P Michas (director) sold 1,953 shares at $54.85 per share price.
Shares of PerkinElmer (PKI) ended Tuesday, Sep 21, 2016 session in red amid volatile trading. The shares closed down -0.5 points or -0.93% at $53.32 with 7,18,746 shares getting traded. Post opening the session at $53.98, the shares hit an intraday low of $53.15 and an intraday high of $54.33 and the price vacillated in this range throughout the day. The company has a market cap of $5,833 M and the number of outstanding shares has been calculated to be 10,94,01,961 shares. The 52-week high of PerkinElmer is $57.28 and the 52-week low is $39.5.
Company has been under the radar of several Street Analysts.PerkinElmer is Downgraded by Mizuho to Neutral and the brokerage firm has set the Price Target at $56. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Aug 5, 2016.
PerkinElmer Inc. is a provider of products services and solutions to the diagnostics research environmental industrial and laboratory services markets. The Company operates its business in two segments: Human Health and Environmental Health. The Companys Human Health segment concentrates on developing diagnostics tools and applications to help detect diseases earlier and more accurately and to accelerate the discovery and development of new therapies. The Companys Environmental Health segment provides products services and solutions to facilitate the creation of safer food and consumer products more secure surroundings and efficient energy resources. The Company markets its products and services in more than 150 countries.